Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0213 EUR | +5.45% |
|
-0.47% | -20.22% |
07-02 | Starbreeze AB Provides Update on Operation Medic Bag | CI |
06-28 | Starbreeze AB Announces PAYDAY 3: "Chapter II: Boys in Blue" Out Now | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company appears to be poorly valued given its net asset value.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.22% | 45.82M | - | ||
+18.40% | 93.41B | B | ||
+16.31% | 86.85B | B+ | ||
+50.44% | 57.52B | D+ | ||
-20.27% | 48.67B | B+ | ||
+36.66% | 48.1B | D+ | ||
-23.37% | 47.45B | B- | ||
+73.68% | 40.4B | D+ | ||
-3.91% | 27.06B | C+ | ||
-18.77% | 23.77B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- STAR B Stock
- 2ST Stock
- Ratings Starbreeze AB